Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Recruiting 1 Completed 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Specimen Handling 479 pembrolizumab 454 Magnetic Resonance Spectroscopy 421 Carboplatin 327 Cyclophosphamide 313 Cisplatin 271 Biopsy 270 Radiotherapy 245 Paclitaxel 230 Gemcitabine 228 Bevacizumab 211 Nivolumab 188 fludarabine 185 venetoclax 174 Drug Therapy 170 Dexamethasone 158 Blood Specimen Collection 158 Oxaliplatin 155 Injections 152 Capecitabine 152 Fluorouracil 144 Docetaxel 142 Standard of Care 135 Radiosurgery 135 Rituximab 125 Pemetrexed 118 durvalumab 115 Leucovorin 108 Radiation 107 atezolizumab 105

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × tipifarnib × 1 year × Clear all

NCT06540963 2026-04-28

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡